JAK inhibitors in alopecia areata

Aug 31 2023 1
JAK inhibitors in alopecia areata Podcast artwork

Join our host, Dr Brittany Craiglow, and patient-advocate, Damien Hamber, discuss the unmet needs in alopecia areata (AA) management, and the importance of treatment selection and shared decision-making. Coming soon – Dr Brittany Craiglow will be joined by her friend and colleague, Dr Leila Asfour, to discuss the pathophysiology of AA, and recent advances in how JAK inhibitors can be utilised for long-term management. This content is intended for Healthcare Professionals only. Not intended for UK audiences.

RSS feed Share
Copy RSS


Subscribe on Podcast Addict


Podcast 1: Unmet needs in the management of alopecia areata

Jul 21 2023 21 mins  
Dermatologist Dr Brittany Craiglow and Damien Hamber, a patient with alopecia areata universalis, describe the unmet medical needs in alopecia areata (AA) management, and the impact of these on patients. Dr Craiglow emphasises for health care professionals, “As a physician…the most important things that I can do is acknowledge the experience and normalise that this is hard.”

Podcast 2: Treatment choice, shared decision-making, and treatment planning for patients with alopecia areata

Jul 21 2023 20 mins  
Treatment selection and planning are fundamental to clinical disease management, but patients also “want to talk to someone who not only understands the condition medically, but the impact that it’s going to have on the individual, and present them with ways forward.” Listen to Damien Hamber, a patient with alopecia areata universalis and patient advocate, and Dr Brittany Cra

Podcast 3: Long-term management of alopecia areata with JAK inhibitors

Aug 31 2023 25 mins  
Although Janus kinase (JAK) inhibitors for AA “can be really life-changing for patients”, Dr Leila Asfour observes that “these are not cures. Often, patients come to the clinic with heightened expectations.” Play the podcast to learn the nuances of using JAK inhibitors for long-term management of AA.

Podcast 4: Progress in basic science research on alopecia areata pathophysiology

Aug 31 2023 13 mins  
Progress in explaining AA pathogenesis, such as identification of the JAK-STAT pathway, has helped determine treatment targets for AA. However, Dr Brittany Craiglow recognises that “We don’t understand that initial inciting event that causes alopecia areata. Patients come into the clinic fixated on the ‘why,’ which is still not well understood.”